1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Riociguat Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 0.5mg
  • 1.3.3 1mg
  • 1.3.4 1.5mg
  • 1.3.5 2mg
  • 1.3.6 2.5mg
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Riociguat Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacy
• 1.5 Global Riociguat Market Size & Forecast
  • 1.5.1 Global Riociguat Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Riociguat Sales Quantity (2021-2032)
  • 1.5.3 Global Riociguat Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Bayer
  • 2.1.1 Bayer Details
  • 2.1.2 Bayer Major Business
  • 2.1.3 Bayer Riociguat Product and Services
  • 2.1.4 Bayer Riociguat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Bayer Recent Developments/Updates
• 2.2 MSD
  • 2.2.1 MSD Details
  • 2.2.2 MSD Major Business
  • 2.2.3 MSD Riociguat Product and Services
  • 2.2.4 MSD Riociguat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 MSD Recent Developments/Updates

3 Competitive Environment: Riociguat by Manufacturer

• 3.1 Global Riociguat Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Riociguat Revenue by Manufacturer (2021-2026)
• 3.3 Global Riociguat Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Riociguat by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Riociguat Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Riociguat Manufacturer Market Share in 2025
• 3.5 Riociguat Market: Overall Company Footprint Analysis
  • 3.5.1 Riociguat Market: Region Footprint
  • 3.5.2 Riociguat Market: Company Product Type Footprint
  • 3.5.3 Riociguat Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Riociguat Market Size by Region
  • 4.1.1 Global Riociguat Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Riociguat Consumption Value by Region (2021-2032)
  • 4.1.3 Global Riociguat Average Price by Region (2021-2032)
• 4.2 North America Riociguat Consumption Value (2021-2032)
• 4.3 Europe Riociguat Consumption Value (2021-2032)
• 4.4 Asia-Pacific Riociguat Consumption Value (2021-2032)
• 4.5 South America Riociguat Consumption Value (2021-2032)
• 4.6 Middle East & Africa Riociguat Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Riociguat Sales Quantity by Type (2021-2032)
• 5.2 Global Riociguat Consumption Value by Type (2021-2032)
• 5.3 Global Riociguat Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Riociguat Sales Quantity by Application (2021-2032)
• 6.2 Global Riociguat Consumption Value by Application (2021-2032)
• 6.3 Global Riociguat Average Price by Application (2021-2032)

7 North America

• 7.1 North America Riociguat Sales Quantity by Type (2021-2032)
• 7.2 North America Riociguat Sales Quantity by Application (2021-2032)
• 7.3 North America Riociguat Market Size by Country
  • 7.3.1 North America Riociguat Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Riociguat Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Riociguat Sales Quantity by Type (2021-2032)
• 8.2 Europe Riociguat Sales Quantity by Application (2021-2032)
• 8.3 Europe Riociguat Market Size by Country
  • 8.3.1 Europe Riociguat Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Riociguat Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Riociguat Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Riociguat Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Riociguat Market Size by Region
  • 9.3.1 Asia-Pacific Riociguat Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Riociguat Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Riociguat Sales Quantity by Type (2021-2032)
• 10.2 South America Riociguat Sales Quantity by Application (2021-2032)
• 10.3 South America Riociguat Market Size by Country
  • 10.3.1 South America Riociguat Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Riociguat Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Riociguat Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Riociguat Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Riociguat Market Size by Country
  • 11.3.1 Middle East & Africa Riociguat Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Riociguat Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Riociguat Market Drivers
• 12.2 Riociguat Market Restraints
• 12.3 Riociguat Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Riociguat and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Riociguat
• 13.3 Riociguat Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Riociguat Typical Distributors
• 14.3 Riociguat Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Riociguat market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Riociguat, sold under the brand name Adempas, is a medication by Bayer that is a stimulator of soluble guanylate cyclase (sGC). It is used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of the class of sGC stimulators. The drug has a half-life of 12 hours and will decrease dyspnea associated with pulmonary arterial hypertension.
This report is a detailed and comprehensive analysis for global Riociguat market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Riociguat market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Riociguat market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Riociguat market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Riociguat market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Riociguat
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Riociguat market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, MSD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Riociguat market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.5mg
1mg
1.5mg
2mg
2.5mg
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Major players covered
Bayer
MSD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riociguat product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Riociguat, with price, sales quantity, revenue, and global market share of Riociguat from 2021 to 2026.
Chapter 3, the Riociguat competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riociguat breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Riociguat market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Riociguat.
Chapter 14 and 15, to describe Riociguat sales channel, distributors, customers, research findings and conclusion.